摘要
AMA Kaczmarek A, Szymajda W, Dettlaff K. Lumateperone in the treatment of psychiatric disorders – a review of the literature. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(1):39-52. doi:10.5114/fpn.2023.127423. APA Kaczmarek, A., Szymajda, W., & Dettlaff, K. (2023). Lumateperone in the treatment of psychiatric disorders – a review of the literature. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 39(1), 39-52. https://doi.org/10.5114/fpn.2023.127423 Chicago Kaczmarek, Ada, Wiktor Szymajda, and Katarzyna Dettlaff. 2023. "Lumateperone in the treatment of psychiatric disorders – a review of the literature". Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii 39 (1): 39-52. doi:10.5114/fpn.2023.127423. Harvard Kaczmarek, A., Szymajda, W., and Dettlaff, K. (2023). Lumateperone in the treatment of psychiatric disorders – a review of the literature. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 39(1), pp.39-52. https://doi.org/10.5114/fpn.2023.127423 MLA Kaczmarek, Ada et al. "Lumateperone in the treatment of psychiatric disorders – a review of the literature." Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, vol. 39, no. 1, 2023, pp. 39-52. doi:10.5114/fpn.2023.127423. Vancouver Kaczmarek A, Szymajda W, Dettlaff K. Lumateperone in the treatment of psychiatric disorders – a review of the literature. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(1):39-52. doi:10.5114/fpn.2023.127423.